Form 8-K/A - Current report: [Amend]
SEC Accession No. 0001104659-24-128088
Filing Date
2024-12-13
Accepted
2024-12-12 17:38:27
Documents
15
Period of Report
2024-07-17
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K/A tm2430889d1_8ka.htm   iXBRL 8-K/A 28308
2 EXHIBIT 99.1 tm2430889d1_ex99-1.htm EX-99.1 10736
6 GRAPHIC tm2430889d1_ex99-1img001.jpg GRAPHIC 9953
  Complete submission text file 0001104659-24-128088.txt   228337

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA gild-20240717.xsd EX-101.SCH 3009
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE gild-20240717_lab.xml EX-101.LAB 34240
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE gild-20240717_pre.xml EX-101.PRE 22355
17 EXTRACTED XBRL INSTANCE DOCUMENT tm2430889d1_8ka_htm.xml XML 3564
Mailing Address 333 LAKESIDE DR FOSTER CITY CA 94404
Business Address 333 LAKESIDE DR FOSTER CITY CA 94404 6505743000
GILEAD SCIENCES, INC. (Filer) CIK: 0000882095 (see all company filings)

EIN.: 943047598 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K/A | Act: 34 | File No.: 000-19731 | Film No.: 241546143
SIC: 2836 Biological Products, (No Diagnostic Substances)
(CF Office: 03 Life Sciences)